Text Size a+ a-

Press Release

CMS Lists Millennium's ACO Amongst Success Stories

Sept. 18, 2014 –   In an announcement from CMS on Tuesday, Millennium’s Accountable Care Organization was named one of the successful Accountable Care Organizations (ACOs) for 2013.  Only 53 ACOs out of 220 across the country were successful in achieving their quality goals AND generated enough savings to get over the CMS established minimum threshold. Millennium was one of them.

“This is a proud moment for the entire Millennium team,” says Brandy Church, spokesperson for Millennium Physician Group.

Millennium’s Accountable Care Organization is listed under CMS documents as ProCare Med, LLC.  A name change was submitted earlier in the year and the ACO is now officially named Millennium Accountable Care Organization.

Millennium’s Accountable Care Organization focuses on delivering measurable quality healthcare for patients while also ensuring that this care is cost effective for patients.

 

Big Announcement Regarding Millennium's ACO

Sept 16, 2014 - The Centers for Medicare & Medicaid Services (CMS) today issued quality and financial performance results showing that Medicare Accountable Care Organizations (ACOs) have improved patient care and produced hundreds of millions of dollars in savings for the program.

In addition to providing more Americans with access to quality, affordable health care, the Affordable Care Act encourages doctors, hospitals and other health care providers to work together to better coordinate care and keep people healthy rather than treat them when they are sick, which also helps to reduce health care costs. ACOs are one example of the innovative ways to improve care and reduce costs.  In an ACO, providers who join these groups become eligible to share savings with Medicare when they deliver that care more efficiently.

ACOs in the Medicare Shared Savings Program (Shared Savings Program) and Pioneer ACO Model generated over $372 million in total program savings for Medicare ACOs.  The encouraging news comes from preliminary quality and financial results from the second year of performance for 23 Pioneer ACOs, and final results from the first year of performance for 220 Shared Savings Program ACOs.

 

Read more: Big Announcement Regarding Millennium's ACO

 

MPG Welcomes Dr. D'Souza

August 7, 2014 –   Millennium Physician Group is proud to welcome Marshall D'Souza, MBBS, M.D., FACP, to our Cape Coral office located on Del Prado Boulevard.

Souza earned his medical degree at Karnatak University in Bellary, India.  He completed his residency at Michigan State University of Michigan's Hurley Medical Center in Flint, Michigan.  He is board certified in Internal Medicine. Dr. D'Souza is a professional member of the Lee County Medical Society and a Fellow of the American College of Physicians.  He has been practicing medicine in Lee County for over 22 years.


Marshall D'Souza, MBBS, M.D., FACP
126 Del Prado Blvd, Suite 104
Cape Coral, Florida 33909
Phone: 239-573-1606

Read more: MPG Welcomes Dr. D'Souza

   

MPG Earns National Recognition from NCQA

August 6, 2014 – Millennium Physician Group has received the highest recognition from the National Committee for Quality Assurance (NCQA) as a Level 3 Patient Centered Medical Home (PCMH).  This recognition is directly linked to physician and staff dedication to patient care.  Only 10 percent of primary care practices in the United States have achieved this recognition.

“We are proud of this recognition from NCQA,” says Geurt Peet, Chief Executive Officer of Millennium Physician Group. “Our team, our staff and our Providers have been working hard behind-the-scenes to ensure that our patients are at the center of our care and that we are actively improving the health care delivery process for our patients.”

NCQA recently announced that 21 of Millennium Physician Group’s 38 primary care offices from Sarasota to Naples have received recognition from the Patient-Centered Medical Home program for using evidence-based, patient-centered processes that focus on coordinated care and long-term participative relationships.

“We expect to have all of our offices recognized as a Patient-Centered Medical Home,” says Peet. “Developing our PCMH program, as well as expanding our Accountable Care Organization, has been critical to changing the way patients receive their health care in a more positive and proactive manner.”

The patient-centered medical home is a model of care emphasizing care coordination and communication to transform primary care into “what patients want it to be”.  Research shows that medical homes can lead to higher quality and lower costs, and improve patients’ and providers’ reported experiences of care.

The PCMH identifies practices that promote partnerships between individual patients and their personal clinicians, instead of treating patients care as the sum of several episodic office visits.  Each patient’s care is tended to by clinician-led care teams, who provide for the patient’s health care needs and coordinate treatments across the health care system.

“The patient-centered medical home raises the bar in defining high-quality care by emphasizing access, health information technology and partnerships between clinicians and patients,” says NCQA President Margaret E. O’Kane.  “PCMH Recognition shows that Millennium Physician Group has the tools, systems and resources to provide their patients with the right care at the right time.”

Read more: MPG Earns National Recognition from NCQA

 

Clinical Trial for Intravascular Thrombosis Patients

Feb. 26, 2014 – Millennium Physician Group will begin its second clinical trial using the CleverCap® medication adherence device-enabled platform. CleverCap® reminds patients to take their medicine on time and in the right dosage each and every day.  While the Group’s first clinical trial focused on medication adherence for diabetic patients,  the second clinical trial will focus on patients who have been diagnosed with Intravascular Thrombosis disease, such as deep vein thrombosis or a pulmonary embolism. 

A group of 100 patients will be selected for the trial separated into two groups of 50.One group will receive a CleverCap® without reminders to measure a utilization benchmark, the second group will receive a fully activated CleverCap® that provides dosing reminders.  The goal is to study the benefits of such technology and whether or not it will improve patient adherence behavior, achieving overall improvements in health outcomes and decreasing chances of a major catastrophic health event that leads to hospitalization.  Millennium is set to begin the trial within the next few months.
 
“Our goal with this clinical trial is to evaluate whether use of the CleverCap® technology improves  medication compliance in patients living with intravascular thrombosis, such as deep vein thrombosis,” says Geurt Peet, Chief Executive Officer for Millennium Physician Group.  “We’ve identified our Physicians who will be championing this effort within our group and we are excited about the chance to develop new programs that could enhance our patients’ health.”

This study is a prospective, randomized, dual center study in patients with intravascular thrombosis who take rivaroxaban – also known as Xarelto® – and whether or not the technology promotes medication adherence.

“Our anticipated study duration is nine months,” says Peet. “We hope that the overall result will show that patients are more consistent with taking their medication and thus improve their overall health.”

Recent research shows only 25 percent of prescription medications are taken as directed and patients are often readmitted to the hospital or their health suffers from not taking the proper medications to treat their illnesses.   Millennium Physician Group has joined this clinical trial in order to tackle the medication non-adherence issue that is quickly growing into one of the largest issues for physicians and hospitals across the United States.  

“CleverCap® has a patented mechanism embedded in the cap that is programmed by the dispensing pharmacy with a digital version of the patient’s prescription instructions in such a way that the CleverCap® actively ‘knows’ when the patient needs to take her prescription and what the dose should be,” says Dr. Juan Rivera, a Millennium physician leading the Clinical Trials in Charlotte Count

Read more: Clinical Trial for Intravascular Thrombosis Patients

   

Page 1 of 12